PYC Therapeutics Limited (PYC.AX)
AUD 1.41
(-6.0%)
AUD 1.41
(-6.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -38.58 Million | -24.42 Million | -21.78 Million | -11.79 Million | -5.74 Million | -5.12 Million |
| Net Income | -37.72 Million | -22.78 Million | -13.86 Million | -17.76 Million | -6.82 Million | -4.07 Million |
| Depreciation & Amortization | 1.06 Million | 882.04 Thousand | 839.5 Thousand | 622.36 Thousand | 547.11 Thousand | 130.55 Thousand |
| Deferred income taxes | - | -3.51 Million | -11.95 Million | -2.5 Million | -1.88 Million | -99.22 Thousand |
| Stock-based compensation | 247.4 Thousand | -70.3 Thousand | 612.72 Thousand | 3.62 Million | 719.96 Thousand | 115.06 Thousand |
| Change in working capital | -2.15 Million | -1.96 Million | -8.94 Million | 2.58 Million | 54.71 Thousand | -15.83 Thousand |
| Other non-cash items | -18.35 Thousand | 3.03 Million | 11.52 Million | 1.64 Million | 1.64 Million | -1.17 Million |
| Investing Cash Flow | -307.04 Thousand | -477.11 Thousand | 32.68 Million | -15.52 Million | -13.77 Million | -4.97 Million |
| Investments in PPE | -307.04 Thousand | -491.11 Thousand | -386.91 Thousand | -591.03 Thousand | -106.09 Thousand | -457.53 Thousand |
| Acquisitions | - | - | - | - | - | 250.00 |
| Investment purchases | - | - | - | -14.88 Million | -13.66 Million | - |
| Sales/Maturities of investments | - | - | 33.06 Million | - | - | - |
| Other Investing Activities | - | 14 Thousand | 1.00 | -49.32 Thousand | -13.66 Million | -4.51 Million |
| Financing Cash Flow | 90.19 Million | 11.44 Million | -182.36 Thousand | 38.55 Million | 25.11 Million | 8.61 Million |
| Debt repayment | -294.48 Thousand | -232.78 Thousand | -182.36 Thousand | -226.64 Thousand | -145.19 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.56 Million | -976.24 Thousand | - | -2.29 Million | -1.62 Million | -503.2 Thousand |
| Common Stock Issuance | 92.05 Million | 11.67 Million | - | 38.78 Million | 25.25 Million | 8.61 Million |
| Other Financing Activities | -294.48 Thousand | 11.44 Million | -182.36 Thousand | 38.55 Million | 25.11 Million | 503.2 Thousand |
| Accounts receivables | -2.43 Million | -6.16 Million | -9.83 Million | -133.32 Thousand | -96.05 Thousand | -15.83 Thousand |
| Accounts payables | 385.08 Thousand | 4.34 Million | 165.71 Thousand | 2.49 Million | 20.99 Thousand | -1.33 Million |
| Inventory | - | - | - | - | 1.00 | 1.27 Million |
| Other working capital | 278.4 Thousand | -139.94 Thousand | 727.07 Thousand | 222.06 Thousand | 129.76 Thousand | 59.18 Thousand |
| Cash at beginning of period | 15.57 Million | 29.11 Million | 18.43 Million | 7.24 Million | 6.18 Million | 3.14 Million |
| Cash at end of period | 66.87 Million | 15.57 Million | 29.11 Million | 18.43 Million | 7.24 Million | 1.66 Million |
| Capital Expenditure | -307.04 Thousand | -491.11 Thousand | -386.91 Thousand | -591.03 Thousand | -106.09 Thousand | -457.53 Thousand |
| Effect of forex changes on cash | 4522.00 | -80.65 Thousand | -40.71 Thousand | -52 Thousand | -9344.00 | - |
| Net cash flow / Change in cash | 51.3 Million | -13.53 Million | 10.67 Million | 11.19 Million | 1.06 Million | -1.48 Million |
| Free Cash Flow | -38.89 Million | -24.91 Million | -22.16 Million | -12.38 Million | -5.85 Million | -5.58 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.63 Million | -37.72 Million | -15.09 Million | -6.55 Million | -22.78 Million | -16.23 Million |
| Depreciation & Amortization | 731.34 Thousand | 1.06 Million | 336.42 Thousand | 93.5 Thousand | 882.04 Thousand | 457.71 Thousand |
| Deferred income taxes | - | - | - | 5.83 Million | -3.51 Million | - |
| Stock-based compensation | 140.58 Thousand | - | 106.82 Thousand | 136.27 Thousand | -70.3 Thousand | -206.57 Thousand |
| Change in working capital | -2.15 Million | -1.77 Million | - | -6.3 Million | -1.96 Million | - |
| Other non-cash items | -7.83 Million | 4.03 Million | 8.59 Million | -5.89 Million | 3.03 Million | 4.81 Million |
| Investing Cash Flow | -27.56 Thousand | -307.04 Thousand | -279.48 Thousand | -347.76 Thousand | -477.11 Thousand | -129.35 Thousand |
| Investments in PPE | -27.56 Thousand | -307.04 Thousand | -279.48 Thousand | -347.76 Thousand | -491.11 Thousand | -143.35 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 14 Thousand | 14 Thousand |
| Financing Cash Flow | 72.92 Million | 90.19 Million | 17.26 Million | 11.54 Million | 11.44 Million | -103.18 Thousand |
| Debt repayment | - | - | -135.27 Thousand | - | -232.78 Thousand | -103.18 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -976.24 Thousand | - |
| Common Stock Issuance | 73.08 Million | 90.48 Million | 17.4 Million | 11.67 Million | 11.67 Million | - |
| Other Financing Activities | 72.92 Million | - | 17.4 Million | 11.54 Million | 11.44 Million | -103.18 Thousand |
| Accounts receivables | -2.43 Million | -2.43 Million | - | -6.16 Million | -6.16 Million | - |
| Accounts payables | - | 385.08 Thousand | - | - | 4.34 Million | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 278.4 Thousand | 278.4 Thousand | - | -139.94 Thousand | -139.94 Thousand | - |
| Cash at beginning of period | 25.41 Million | 15.57 Million | 15.57 Million | 17.07 Million | 29.11 Million | 29.11 Million |
| Cash at end of period | 66.87 Million | 66.87 Million | 25.41 Million | 15.57 Million | 15.57 Million | 17.07 Million |
| Capital Expenditure | -27.56 Thousand | -307.04 Thousand | -279.48 Thousand | -347.76 Thousand | -491.11 Thousand | -143.35 Thousand |
| Effect of forex changes on cash | 308.77 Thousand | - | -304.25 Thousand | -161.48 Thousand | -80.65 Thousand | 80.83 Thousand |
| Net cash flow / Change in cash | 41.46 Million | 51.3 Million | 9.84 Million | -1.5 Million | -13.53 Million | -12.03 Million |
| Free Cash Flow | -31.77 Million | -38.89 Million | -7.11 Million | -12.89 Million | -24.91 Million | -12.02 Million |
0403
PPLFY
MET-PA
0152
C09
JIN